InvestorsHub Logo
Followers 7
Posts 789
Boards Moderated 0
Alias Born 11/20/2003

Re: railroadman post# 11849

Saturday, 12/02/2017 12:12:57 PM

Saturday, December 02, 2017 12:12:57 PM

Post# of 12450
I think the biggest catalyst will be the
Announcement of as partner for tadafil.

Since the licensed this from Lily I think that whoever partners will have a 2 year window of excluvity before the genetics kick in.

I think that this could potentially a multi million dollar payment,plus royalties ,plus their manufacturing of film profit.

They have been gearing up for this in their expansion of the olant very quietly. I think that is the biggest catalyst.

They have not mentioned anything about their other outside contracts like with Tetra.

The loss of the nalaxone patent I think
sets them up to imitate An appeal or another course of action.

They have not mentioned overages in the sales of the drug that they sold their receivable for such as sales numbers.

no Mention of their cms drugs.

The monteelust is slowly progressing.

The other drugs are progressing but no
announcements yet that would be a definite catalyst

Hopefully in 2018 we will have a triple crown winner over $1 very easily

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGXT News